# Thrice-weekly Versus Thrice-daily Oral Ferrous Fumarate Treatment in Adult Patients With Iron Deficiency Anemia

> **NCT04130828** · PHASE3 · COMPLETED · sponsor: **Prince of Songkla University** · enrollment: 66 (actual)

## Conditions studied

- Iron Deficiency Anemia

## Interventions

- **DRUG:** Ferrous Fumarate

## Key facts

- **NCT ID:** NCT04130828
- **Lead sponsor:** Prince of Songkla University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-21
- **Primary completion:** 2022-01-18
- **Final completion:** 2022-01-18
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2022-02-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04130828

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04130828, "Thrice-weekly Versus Thrice-daily Oral Ferrous Fumarate Treatment in Adult Patients With Iron Deficiency Anemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04130828. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*